Neurotoxicity and Memory Deficits Induced by Soluble Low-Molecular-Weight Amyloid- 1-42 Oligomers Are Revealed In Vivo by Using a Novel Animal Model
Jonathan Brouillette(Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal), Luc Buée(Inserm)
Cited by 171
Related Papers
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology
|Molecular Psychiatry|2013|440
Alzheimer's Disease-Like Tau Neuropathology Leads to Memory Deficits and Loss of Functional Synapses in a Novel Mutated Tau Transgenic Mouse without Any Motor Deficits
|American Journal Of Pathology|2006|383
Tau Phosphorylation and Sevoflurane Anesthesia
|Anesthesiology|2012|212
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease
|Molecular Psychiatry|2009|203